Ginkgo Bioworks Holdings (DNA) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$1.45.
- Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) fell 3425.93% to -$1.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.19, marking a year-over-year increase of 5205.27%. This contributed to the annual value of -$10.54 for FY2024, which is 4261.08% up from last year.
- Latest data reveals that Ginkgo Bioworks Holdings reported EPS (Weighted Average and Diluted) of -$1.45 as of Q3 2025, which was down 3425.93% from -$1.1 recorded in Q2 2025.
- Over the past 5 years, Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) peaked at -$0.04 during Q2 2021, and registered a low of -$49.01 during Q4 2022.
- In the last 5 years, Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) had a median value of -$1.14 in 2021 and averaged -$4.29.
- In the last 5 years, Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) soared by 9111.43% in 2023 and then crashed by 460000.0% in 2024.
- Ginkgo Bioworks Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at -$1.18 in 2021, then crashed by 4054.02% to -$49.01 in 2022, then surged by 91.11% to -$4.35 in 2023, then skyrocketed by 52.42% to -$2.07 in 2024, then soared by 30.02% to -$1.45 in 2025.
- Its EPS (Weighted Average and Diluted) was -$1.45 in Q3 2025, compared to -$1.1 in Q2 2025 and -$1.68 in Q1 2025.